FR2492260B1 - - Google Patents
Info
- Publication number
- FR2492260B1 FR2492260B1 FR8119522A FR8119522A FR2492260B1 FR 2492260 B1 FR2492260 B1 FR 2492260B1 FR 8119522 A FR8119522 A FR 8119522A FR 8119522 A FR8119522 A FR 8119522A FR 2492260 B1 FR2492260 B1 FR 2492260B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55144508A JPS5770814A (en) | 1980-10-17 | 1980-10-17 | Oral preparation of blood clotting eighth factor |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2492260A1 FR2492260A1 (en) | 1982-04-23 |
FR2492260B1 true FR2492260B1 (en) | 1984-07-27 |
Family
ID=15363986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8119522A Granted FR2492260A1 (en) | 1980-10-17 | 1981-10-16 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING COAGULATION FACTOR VIII |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5770814A (en) |
DE (1) | DE3141223A1 (en) |
ES (1) | ES506320A0 (en) |
FR (1) | FR2492260A1 (en) |
GB (1) | GB2085729B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4536392A (en) * | 1983-06-27 | 1985-08-20 | Queen's University At Kingston | Method for controlling hemophilia in mammals |
IT1164363B (en) * | 1983-08-03 | 1987-04-08 | Foscama Biomed Chim Farma | THERAPEUTIC PROCEDURE FOR THE USE OF EMBORNED LIPOSOMES FRUCTOSE 1.6 DIPHOSPHATE AND PROCEDURE FOR THE PREPARATION OF THE SAME |
JPS6150912A (en) * | 1984-08-16 | 1986-03-13 | Shionogi & Co Ltd | Production of liposome preparation |
FR2581543B1 (en) * | 1985-05-09 | 1989-07-07 | Tressens Dominique | PHARMACOTECHNIE ALLOWING THE PRODUCTION OF AN ORAL ACTIVE INSULIN PREPARATION |
DE3625090A1 (en) * | 1986-07-24 | 1988-01-28 | Behringwerke Ag | AGENT FOR THE THERAPY FACTOR VIII-RESISTANT HAEMOPHILY A AND METHOD FOR THE PRODUCTION THEREOF |
GB8822857D0 (en) * | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
GB9007052D0 (en) * | 1990-03-29 | 1990-05-30 | Skua Investments Ltd | Pharmaceutical formulations |
DE4115453A1 (en) * | 1991-05-11 | 1992-11-12 | Knoll Ag | NEW ACTIVE COMPOUND |
WO1994028876A1 (en) * | 1993-06-07 | 1994-12-22 | Advanced Therapies, Inc. | Liposome powders |
FR2706302B1 (en) * | 1993-06-18 | 1995-08-18 | Franche Comte Universite | Basifying product in gastro-resistant form. |
US6017891A (en) * | 1994-05-06 | 2000-01-25 | Baxter Aktiengesellschaft | Stable preparation for the treatment of blood coagulation disorders |
DE4416180C2 (en) * | 1994-05-06 | 1997-08-14 | Immuno Ag | Stable preparation for the treatment of blood coagulation disorders and method for producing this preparation |
DE4416166C2 (en) * | 1994-05-06 | 1997-11-20 | Immuno Ag | Stable preparation for the treatment of blood clotting disorders |
CH689139A5 (en) * | 1995-04-03 | 1998-10-30 | Cerbios Pharma Sa | Process for the preparation of a liposomal, in water dispersable, orally administrable, solid, dry therapeutic formulation. |
AU9221698A (en) * | 1997-09-04 | 1999-03-22 | Biozone Laboratories, Inc. | Oral liposomal delivery system |
DE60035260T2 (en) | 1999-02-22 | 2007-10-18 | The University Of Connecticut, Farmington | NEW ALBUMIN FREE FACTOR VIII FORMULATIONS |
NZ593190A (en) | 2008-11-07 | 2013-01-25 | Baxter Int | Factor viii formulations |
DE102009001334B4 (en) | 2009-03-04 | 2017-02-23 | Stefan Brosig | Simple enteric encapsulation, e.g. of ginger and other delicate substances |
CN109316599A (en) * | 2018-08-24 | 2019-02-12 | 上海交通大学医学院附属瑞金医院 | A kind of Aprotinin or its mutant, derivative, analog or its application for forming segment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2249552A1 (en) * | 1971-10-12 | 1973-05-30 | Inchema S A | PROCESS FOR THE INCAPSULATION OF IN PARTICULAR WATER-SOLUBLE COMPOUNDS |
NL7900459A (en) * | 1979-01-19 | 1980-07-22 | Hendrik Coenraad Hemker Prof D | PHARMACEUTICAL PREPARATION AND METHOD OF PREPARATION THEREOF. |
-
1980
- 1980-10-17 JP JP55144508A patent/JPS5770814A/en active Granted
-
1981
- 1981-10-06 GB GB8130122A patent/GB2085729B/en not_active Expired
- 1981-10-16 DE DE19813141223 patent/DE3141223A1/en not_active Withdrawn
- 1981-10-16 FR FR8119522A patent/FR2492260A1/en active Granted
- 1981-10-16 ES ES506320A patent/ES506320A0/en active Granted
Also Published As
Publication number | Publication date |
---|---|
GB2085729B (en) | 1984-04-18 |
GB2085729A (en) | 1982-05-06 |
JPS5770814A (en) | 1982-05-01 |
ES8306323A1 (en) | 1983-05-16 |
ES506320A0 (en) | 1983-05-16 |
DE3141223A1 (en) | 1982-06-24 |
JPH03366B2 (en) | 1991-01-07 |
FR2492260A1 (en) | 1982-04-23 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |